We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $699M
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
+17.55%
3 Year Est. Return
+73.49%
5 Year Est. Return
+86.81%
10 Year Est. Return
+260.19%
AUM
$224M
AUM Growth
+$13.5M
Cap. Flow
+$5.43M
Cap. Flow %
2.43%
Top 10 Hldgs %
37.65%
Holding
112
New
1
Increased
61
Reduced
31
Closed
1
Avg Time Held
9.9 quarters
Top 10 Avg Time Held
9.7 quarters
Top 20 Avg Time Held
9.8 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$703K
2
CVX icon
Chevron
CVX
+$602K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$453K
4
PFE icon
Pfizer
PFE
+$419K
5
IP icon
International Paper
IP
+$394K

Sector Composition

Rank Sector Weight
1 Industrials 19.7%
2 Healthcare 16.38%
3 Consumer Staples 12.55%
4 Miscellaneous 10.26%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BRK.A icon
101
Berkshire Hathaway Class A
BRK.A
$1.11T
$217K 0.1%
1
– –
2016 Q1
1 quarter
SPY icon
102
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$212K 0.09%
1,010
-500
-33% -$104K
2014 Q4
6 quarters
XLE icon
103
State Street Energy Select Sector SPDR ETF
XLE
$43.2B
$208K 0.09%
+6,100
New +$201K
2016 Q2
0 quarters
CPGX
104
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
$206K 0.09%
8,071
-1,150
-12% -$29.3K
2016 Q1
1 quarter
ONB icon
105
Old National Bancorp
ONB
$9.42B
$200K 0.09%
15,936
– –
2013 Q2
12 quarters
FCF icon
106
First Commonwealth Financial
FCF
$2.02B
$129K 0.06%
14,000
– –
2015 Q2
4 quarters
CGEN icon
107
Compugen
CGEN
$188M
$65K 0.03%
10,000
– –
2013 Q2
12 quarters
AKS
108
DELISTED
AK Steel Holding Corp
AKS
$47K 0.02%
10,000
– –
2014 Q3
7 quarters
NAVB
109
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$10K ﹤0.01%
900
– –
2013 Q2
12 quarters
BRBI icon
110
DELISTED
BLUE RIVER BANCSHARES INC
BRBI
$3K ﹤0.01%
124,708
– –
2013 Q2
12 quarters
IWB icon
111
iShares Russell 1000 ETF
IWB
$49.6B
– –
-1,810
Closed -$206K –

Similar funds

Lynch & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Lynch & Associates held 112 positions worth $224M, up 6.4% from $210M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.8%. Lynch & Associates opened 1 new position and exited 1, leaving the 112-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Lynch & Associates's largest Q2 2016 buy was State Street Energy Select Sector SPDR ETF: 6,100 shares worth $208K.
  • Lynch & Associates added most to Merck in Q2 2016, an estimated $703K increase.
  • Lynch & Associates's biggest Q2 2016 reduction was Kearny Financial, cutting an estimated $654K.
  • Lynch & Associates fully exited iShares Russell 1000 ETF in Q2 2016, selling an estimated $206K.
  • Lynch & Associates's ten largest holdings make up 38% of its $224M portfolio in Q2 2016.
  • Lynch & Associates opened 1 new position and closed 1 in Q2 2016.
  • Lynch & Associates's portfolio value rose 6.4% quarter-over-quarter to $224M.

Based on Lynch & Associates's 13F filing for Q2 2016, filed 20 Jul 2016.